{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:35:23Z","timestamp":1791250523329,"version":"4.1.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2006,6,19]],"date-time":"2006-06-19T00:00:00Z","timestamp":1150675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,6,19]],"date-time":"2006-06-19T00:00:00Z","timestamp":1150675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1111\/j.1365-2133.2006.07390.x","type":"journal-article","created":{"date-parts":[[2006,6,19]],"date-time":"2006-06-19T10:28:31Z","timestamp":1150712911000},"page":"714-721","source":"Crossref","is-referenced-by-count":175,"title":["Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature"],"prefix":"10.1093","volume":"155","author":[{"given":"I.","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Maurey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-F.","family":"Hellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,6,19]]},"reference":[{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.autrev.2003.11.001","article-title":"Fifth international symposium on IvIg: IvIg in the third millenium, 25-27 September 2003, Interlaken, Switzerland: a meeting review","volume":"3","author":"Shoenfeld","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08916930500059633","article-title":"IvIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients","volume":"38","author":"Shoenfeld","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/01.WNL.0000074394.15882.83","article-title":"Strokes, thromboembolic events, and IvIg: rare incidents blemish an excellent safety record","volume":"60","author":"Dalakas","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1212\/WNL.49.3.899-b","article-title":"Complications of intravenous immune globulin treatment in neurologic disease","volume":"49","author":"Achiron","year":"1997","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.47.3.674","article-title":"Complications of intravenous immune globulin treatment in neurologic disease","volume":"47","author":"Brannagan","year":"1996","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.44.2.223","article-title":"High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events","volume":"44","author":"Dalakas","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB7|cit7","first-page":"375","article-title":"Intravenous immunoglobulin: a life-saving (and potentially fatal) treatment","volume":"73","author":"Elston","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1592\/phco.22.17.1638.34125","article-title":"Thrombotic complications after intravenous immunoglobulin therapy in two patients","volume":"22","author":"Emerson","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1212\/01.WNL.0000068334.04500.08","article-title":"Arterial thrombosis induced by IvIg and its treatment with tPA","volume":"60","author":"Okuda","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0248-8663(03)00137-1","article-title":"Tol\u00e9rance clinique d'une pr\u00e9paration th\u00e9rapeutique d'immunoglobulines intraveineuses polyvalentes \u00e0 usage veineux (Endobuline\u00ae): suivi prospectif d'une population de 142 adultes et enfants","volume":"24","author":"Pautard","year":"2003","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00415-003-1085-1","article-title":"Side effects of intravenous immunoglobulins in neurological autoimmune disorders-a prospective study","volume":"250","author":"Stangel","year":"2003","journal-title":"J Neurol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000073059","article-title":"Therapy with intravenous immunoglobulins: complications and side-effects","volume":"50","author":"Wittstock","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1468-1331.2003.00542.x","article-title":"Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature","volume":"10","author":"Zaidan","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-139-4-200308190-00025-w3","article-title":"Acute renal failure and myocarditis associated with intravenous immunoglobulin therapy","volume":"139","author":"Akhtar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/ndt\/16.7.1513","article-title":"Immunoglobulin as a risk factor for contrast media nephrotoxicity","volume":"16","author":"Bassilios","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ard.59.1.77","article-title":"Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases","volume":"59","author":"Elkayam","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00277-004-0895-2","article-title":"Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature","volume":"83","author":"Hefer","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2001.02742.x","article-title":"Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy","volume":"113","author":"Sati","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajh.20287","article-title":"Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence","volume":"78","author":"Alexandrescu","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/014107680109400412","article-title":"Pulmonary embolism after intravenous immunoglobulin","volume":"94","author":"Alliot","year":"2001","journal-title":"J R Soc Med"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1253\/circj.69.962","article-title":"Single high-dose intravenous immunoglobulin therapy for Kawasaki disease increases plasma viscosity","volume":"69","author":"Baba","year":"2005","journal-title":"Circ J"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0091-6749(03)01780-9","article-title":"Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients","volume":"112","author":"Brown","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1345\/aph.1D037L","article-title":"Pulmonary embolism associated with intravenous immunoglobulin therapy","volume":"37","author":"Butler","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1212\/WNL.59.3.458","article-title":"Neuropathologic findings in a Guillain-Barre patient with strokes after IVIg therapy","volume":"59","author":"Byrne","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/01.WNL.0000068335.01620.9D","article-title":"The clinical features of 16 cases of stroke associated with administration of IVIg","volume":"60","author":"Caress","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0248-8663(99)80064-2","article-title":"Insuffisance r\u00e9nale aigu\u00eb et infarctus c\u00e9r\u00e9bral au d\u00e9cours d'un traitement par immunoglobulines intraveineuses \u00e0 fortes doses","volume":"19","author":"Chatot-Henry","year":"1998","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/000331970205300117","article-title":"Intravenous immunoglobulin-related acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura-a case report and literature review","volume":"53","author":"Crouch","year":"2002","journal-title":"Angiology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ajh.2830440321","article-title":"Deleterious effects of intravenous immunoglobulin in a patient with thrombotic thrombocytopenic purpura","volume":"44","author":"Durand","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jcp.56.4.308","article-title":"Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatment","volume":"56","author":"Evangelou","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1055\/s-0037-1613737","article-title":"Deep vein thrombosis after intravenous immunoglobulins associated with methylprednisolone","volume":"92","author":"Feuillet","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB31|cit31","first-page":"775","article-title":"Intravenous immunoglobulin, blood viscosity and myocardial infarction","volume":"13","author":"Fisman","year":"1997","journal-title":"Can J Cardiol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(86)92182-3","article-title":"Thrombotic events after intravenous immunoglobulin","volume":"2","author":"Frame","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4065\/75.1.83","article-title":"Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications","volume":"75","author":"Go","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/eye.2000.163","article-title":"Central retinal vein occlusion complicating treatment with intravenous immunoglobulin","volume":"14","author":"Harkness","year":"2000","journal-title":"Eye"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(04)17101-8","article-title":"Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial","volume":"364","author":"Hommes","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archderm.139.8.991","article-title":"Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions","volume":"139","author":"Katz","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0002-9394(14)70844-X","article-title":"Iatrogenic central retinal vein occlusion and hyperviscosity associated with high-dose intravenous immunoglobulin administration","volume":"124","author":"Oh","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1096-8652(200010)65:2<177::AID-AJH17>3.0.CO;2-K","article-title":"Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP)","volume":"65","author":"Paolini","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.mbc.0000172694.85233.a8","article-title":"Venous and arterial thrombosis following administration of intravenous immunoglobulins","volume":"16","author":"Paran","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/art.38","article-title":"Myocardial infarction as a complication of immunoglobulin therapy","volume":"40","author":"Rosenbaum","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB41|cit41","first-page":"403","article-title":"Deep venous thrombosis after high-dose intravenous immunoglobulin in the treatment of pemphigus vulgaris","volume":"73","author":"Sheehan","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.42.1.257","article-title":"Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis","volume":"42","author":"Silbert","year":"1992","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000075091","article-title":"Acute myocardial infarction following intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy in association with a monoclonal immunoglobulin G paraprotein","volume":"51","author":"Stamboulis","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1212\/WNL.44.6.1180","article-title":"Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis","volume":"44","author":"Steg","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB45|cit45","first-page":"115","article-title":"Intravenous immune globulin (IVIG) precipitating acute myocardial infarction","volume":"43","author":"Struble","year":"2002","journal-title":"J Miss State Med Assoc"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/jnnp.68.6.790","article-title":"Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome","volume":"68","author":"Turner","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000081465","article-title":"Thromboembolic complications of intravenous immunoglobulin treatment","volume":"52","author":"Vucic","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000070197","article-title":"High-dose corticosteroid treatment is associated with an increased risk of developing cerebral venous thrombosis","volume":"49","author":"Stolz","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"H2663","DOI":"10.1152\/ajpheart.00128.2003","article-title":"A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation","volume":"285","author":"Ben-Ami","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.57.9.1699","article-title":"Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders","volume":"57","author":"Grillo","year":"2001","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0140-6736(92)90806-E","article-title":"Effect of high-dose intravenous immunoglobulin therapy on blood rheology","volume":"339","author":"Reinhart","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.10325","article-title":"Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia","volume":"73","author":"Steinberger","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1096-8652(200009)65:1<30::AID-AJH5>3.0.CO;2-J","article-title":"Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations","volume":"65","author":"Wolberg","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(86)92511-0","article-title":"Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients","volume":"2","author":"Woodruff","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1023\/A:1023239904856","article-title":"Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in na\u00efve mice","volume":"18","author":"Krause","year":"1998","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000056085","article-title":"Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases","volume":"62","author":"Sherer","year":"2001","journal-title":"Pharmacology"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-510X(97)00292-X","article-title":"Intravenous immunoglobulin treatment of neurological autoimmune diseases","volume":"153","author":"Stangel","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000008040","article-title":"High-dose intravenous immunoglobulin treatment and cerebral vasospasm: a possible mechanism of ischemic encephalopathy","volume":"41","author":"Sztajzel","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1365-2133.2006.07390.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.46.1.250","article-title":"Reversible encephalopathy with cerebral vasospasm in a Guillain-Barr\u00e9 syndrome patient treated with intravenous immunoglobulin","volume":"46","author":"Voltz","year":"1996","journal-title":"Neurology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07390.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07390.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2006.07390.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:17:55Z","timestamp":1676384275000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/155\/4\/714\/6636892"}},"subtitle":["IvIg-related thrombotic complications"],"short-title":[],"issued":{"date-parts":[[2006,6,19]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07390.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6,19]]}}}